Stock Analyses

LCCCR

Lakeshore Acquisition III Corp.

Valuation N/A

Financial Services

Price$0.15

Model IV—

P/IV—

LCCCU

Lakeshore Acquisition III Corp.

Valuation N/A

Financial Services

Price$10.61

Model IV—

P/IV—

LCFY

Locafy Ltd

Valuation N/A

Technology

Price$2.44

Model IV—

P/IV—

LCFYW

Locafy Ltd

Valuation N/A

Technology

Price$4.80

Model IV—

P/IV—

Market implies +28.9%/yr vs model +6.1% · above model

LCID

Lucid Group, Inc.

Valuation N/A

Consumer Cyclical

Price$4.22

Model IV—

P/IV—

Market implies +62.7%/yr vs model +8.0% · above model

LCII

LCI INDUSTRIES

Deeply undervalued

Consumer Cyclical

Price$90.19

Model IV$154.31

P/IV0.71

Discount 42% Return to IV: +71.1%

Owner yield 15.9% 10-yr IRR 24.5% · steady

Market implies -5.1%/yr vs model +3.0% · below model

LCLN

Lincoln International, Inc.

Valuation N/A

Financial Services

Price$26.81

Model IV—

P/IV—

LCNB

LCNB CORP

Fairly valued

Financial Services

Price$19.11

Model IV$15.24

P/IV1.12

Premium +25% Return to IV: -20.2%

LCTX

Lineage Cell Therapeutics, Inc.

Valuation N/A

Healthcare

Price$1.01

Model IV—

P/IV—

Market implies +28.1%/yr vs model +35.3% · below model

LCUT

LIFETIME BRANDS, INC

Deeply undervalued

Industrials

Price$8.58

Model IV$19.17

P/IV0.45

Discount 55% Return to IV: +123.4%

Market implies -15.3%/yr vs model +2.0% · below model

LDI

loanDepot, Inc.

Valuation N/A

Financial Services

Price$0.84

Model IV—

P/IV—

Market implies -17.3%/yr vs model +2.0% · below model

LDOS

Leidos Holdings, Inc.

Deeply undervalued

Technology

Price$127.69

Model IV$349.51

P/IV0.37

Discount 63% Return to IV: +173.7%

Owner yield 7.8% 10-yr IRR 18.0% · moderate

Market implies -4.9%/yr vs model +10.1% · below model

LDP

Cohen & Steers Ltd Duration Preferred & Income Fund, Inc.

Valuation N/A

Unknown

Price$19.95

Model IV—

P/IV—

LE

LANDS' END, INC.

Overvalued

Consumer Cyclical

Price$10.37

Model IV$9.49

P/IV1.24

Premium +9% Return to IV: -8.5%

Owner yield 13.6% 10-yr IRR 19.6% · steady

Market implies +1.0%/yr vs model +1.0% · in line

LEA

LEAR CORP

Fairly valued

Consumer Cyclical

Price$126.18

Model IV$134.04

P/IV1.07

Discount 6% Return to IV: +6.2%

Owner yield 8.4% 10-yr IRR 15.6% · steady

Market implies +3.9%/yr vs model +5.8% · in line

LECO

LINCOLN ELECTRIC HOLDINGS INC

Deeply overvalued

Industrials

Price$253.06

Model IV$170.20

P/IV1.52

Premium +49% Return to IV: -32.7%

Owner yield 3.8% 10-yr IRR 6.1% · moderate

Market implies +12.3%/yr vs model +8.5% · above model

LEDS

SemiLEDs Corp

Deeply undervalued

Technology

Price$2.15

Model IV$3.54

P/IV0.64

Discount 39% Return to IV: +64.7%

Market implies +7.2%/yr vs model +25.0% · below model

LEE

LEE ENTERPRISES, Inc

Valuation N/A

Communication Services

Price$7.69

Model IV—

P/IV—

Market implies +25.5%/yr vs model +0.0% · above model

LEG

LEGGETT & PLATT INC

Undervalued

Consumer Cyclical

Price$9.20

Model IV$12.39

P/IV0.83

Discount 26% Return to IV: +34.6%

Owner yield 23.0% 10-yr IRR 28.2% · steady

Market implies -8.6%/yr vs model -1.4% · below model

LEGH

Legacy Housing Corp

Deeply overvalued

Industrials

Price$27.67

Model IV$8.74

P/IV2.75

Premium +217% Return to IV: -68.4%

Owner yield 1.7% 10-yr IRR -11.7% · steady

Market implies +9.6%/yr vs model -4.1% · above model

LEGN

Legend Biotech Corp

Valuation N/A

Healthcare

Price$18.64

Model IV—

P/IV—

LEGO

Legato Merger Corp. IV

Valuation N/A

Financial Services

Price$10.00

Model IV—

P/IV—

LEGT

Legato Merger Corp. III

Valuation N/A

Financial Services

Price$9.52

Model IV—

P/IV—

LEN

LENNAR CORP /NEW/

Deeply undervalued

Industrials

Price$76.43

Model IV$131.89

P/IV0.68

Discount 42% Return to IV: +72.6%

Owner yield 12.4% 10-yr IRR 22.4% · steady

Market implies -2.6%/yr vs model +6.0% · below model

LENZ

LENZ Therapeutics, Inc.

Valuation N/A

Healthcare

Price$4.23

Model IV—

P/IV—

Market implies +26.5%/yr vs model +15.0% · above model

LEO

BNY MELLON STRATEGIC MUNICIPALS, INC.

Valuation N/A

Unknown

Price$5.92

Model IV—

P/IV—

LESL

Leslie's, Inc.

Valuation N/A

Consumer Cyclical

Price$0.50

Model IV—

P/IV—

Market implies -50.0%/yr vs model +2.0% · below model

LEU

CENTRUS ENERGY CORP

Valuation N/A

Basic Materials

Price$146.25

Model IV—

P/IV—

Owner yield 0.8% 10-yr IRR -11.1% · moderate

Market implies +42.3%/yr vs model +8.0% · above model

LEVI

LEVI STRAUSS & CO

Deeply overvalued

Consumer Cyclical

Price$20.16

Model IV$9.06

P/IV2.56

Premium +123% Return to IV: -55.1%

Owner yield 4.6% 10-yr IRR 5.7% · steady

Market implies +15.3%/yr vs model +4.5% · above model

LEXX

Lexaria Bioscience Corp.

Valuation N/A

Healthcare

Price$3.21

Model IV—

P/IV—

Market implies +77.1%/yr vs model +2.0% · above model

LFAC

Leapfrog Acquisition Corp

Valuation N/A

Financial Services

Price$10.07

Model IV—

P/IV—

LFACW

Leapfrog Acquisition Corp

Valuation N/A

Financial Services

Price$0.28

Model IV—

P/IV—

LFCR

LIFECORE BIOMEDICAL, INC. DE

Deeply overvalued

Healthcare

Price$4.12

Model IV$2.86

P/IV1.75

Premium +44% Return to IV: -30.5%

Market implies +1.7%/yr vs model +6.3% · below model

LFMD

LifeMD, Inc.

Deeply undervalued

Healthcare

Price$3.05

Model IV$5.34

P/IV0.80

Discount 43% Return to IV: +75.0%

Market implies -6.8%/yr vs model +20.2% · below model

LFMDP

LifeMD, Inc.

Fairly valued

Healthcare

Price$23.32

Model IV$25.60

P/IV0.93

Discount 9% Return to IV: +9.8%

Market implies -10.9%/yr vs model +20.2% · below model

LFS

LEIFRAS Co., Ltd.

Undervalued

Consumer Defensive

Price$2.19

Model IV$3.24

P/IV0.82

Discount 32% Return to IV: +47.9%

Market implies +0.4%/yr vs model +9.0% · below model

LFST

LifeStance Health Group, Inc.

Deeply overvalued

Healthcare

Price$12.97

Model IV$3.24

P/IV2.38

Premium +300% Return to IV: -75.0%

Market implies +32.4%/yr vs model +17.6% · above model

LFT

Lument Finance Trust, Inc.

Deeply undervalued

Financial Services

Price$6.66

Model IV$4.93

P/IV0.21

Premium +35% Return to IV: -26.0%

LFUS

LITTELFUSE INC /DE

Deeply overvalued

Technology

Price$432.30

Model IV$135.06

P/IV3.46

Premium +220% Return to IV: -68.8%

Owner yield 3.2% 10-yr IRR 0.1% · steady

Market implies +19.8%/yr vs model +3.0% · above model

LFVN

Lifevantage Corp

Deeply overvalued

Healthcare

Price$6.17

Model IV$4.73

P/IV1.67

Premium +31% Return to IV: -23.4%

Owner yield 10.1% 10-yr IRR 18.7% · steady

Market implies +6.6%/yr vs model +6.0% · in line

LFWD

Lifeward Ltd.

Valuation N/A

Healthcare

Price$7.12

Model IV—

P/IV—

Market implies +33.8%/yr vs model +2.0% · above model

LGCL

Lucas GC Ltd

Valuation N/A

Technology

Price$3.15

Model IV—

P/IV—

Market implies -50.0%/yr vs model +15.0% · below model

LGCY

Legacy Education Inc.

Deeply undervalued

Consumer Defensive

Price$10.35

Model IV$17.09

P/IV0.65

Discount 39% Return to IV: +65.1%

Market implies +9.7%/yr vs model +25.0% · below model

LGHL

Lion Group Holding Ltd

Valuation N/A

Financial Services

Price$8.30

Model IV—

P/IV—

LGI

LAZARD GLOBAL TOTAL RETURN & INCOME FUND INC

Valuation N/A

Unknown

Price$17.47

Model IV—

P/IV—

LGIH

LGI Homes, Inc.

Deeply overvalued

Industrials

Price$49.42

Model IV$23.49

P/IV2.04

Premium +110% Return to IV: -52.5%

Market implies +12.1%/yr vs model +2.0% · above model

LGL

LGL GROUP INC

Deeply overvalued

Technology

Price$6.78

Model IV$1.57

P/IV4.54

Premium +333% Return to IV: -76.9%

Market implies +7.9%/yr vs model +14.1% · below model

LGN

Legence Corp.

Valuation N/A

Industrials

Price$56.65

Model IV—

P/IV—

LGND

LIGAND PHARMACEUTICALS INC

Valuation N/A

Healthcare

Price$284.47

Model IV—

P/IV—

Market implies +36.2%/yr vs model +2.6% · above model

LGO

Largo Inc.

Valuation N/A

Basic Materials

Price$0.68

Model IV—

P/IV—

LGPS

LOGPROSTYLE INC.

Valuation N/A

Industrials

Price$0.83

Model IV—

P/IV—

LGVN

Longeveron Inc.

Valuation N/A

Healthcare

Price$7.33

Model IV—

P/IV—

Market implies +150.0%/yr vs model +14.1% · above model

LH

LABCORP HOLDINGS INC.

Undervalued

Healthcare

Price$320.71

Model IV$397.08

P/IV0.65

Discount 19% Return to IV: +23.8%

Owner yield 3.9% 10-yr IRR 6.2% · moderate

Market implies +3.6%/yr vs model +7.8% · below model

LHAI

Linkhome Holdings Inc.

Overvalued

Real Estate

Price$1.04

Model IV$0.76

P/IV1.21

Premium +37% Return to IV: -27.2%

Market implies +19.5%/yr vs model +25.0% · below model

LHSW

Lianhe Sowell International Group Ltd

Valuation N/A

Technology

Price$0.62

Model IV—

P/IV—

Market implies -47.7%/yr vs model +50.0% · below model

LHX

L3HARRIS TECHNOLOGIES, INC. /DE/

Deeply undervalued

Industrials

Price$247.29

Model IV$390.56

P/IV0.81

Discount 37% Return to IV: +57.9%

Owner yield 4.6% 10-yr IRR 8.6% · moderate

Market implies +0.8%/yr vs model +8.0% · below model

LI

Li Auto Inc.

Deeply overvalued

Consumer Cyclical

Price$11.76

Model IV$4.59

P/IV3.27

Premium +156% Return to IV: -61.0%

Owner yield 7.3% 10-yr IRR 15.2% · moderate

Market implies +19.4%/yr vs model +8.0% · above model

LICN

Lichen International Ltd

Valuation N/A

Industrials

Price$1.04

Model IV—

P/IV—

Market implies +36.1%/yr vs model +2.0% · above model

LIDR

AEye, Inc.

Valuation N/A

Consumer Cyclical

Price$1.21

Model IV—

P/IV—

Market implies +45.3%/yr vs model +8.0% · above model

LIDRW

LIDRW

Valuation N/A

Price$0.00

Model IV—

P/IV—